Deutsche Bank analyst Falko Friedrichs lowered the firm’s price target on Fresenius Medical (FMS) to EUR 48 from EUR 50 and keeps a Hold rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Hold Rating Maintained for Fresenius Medical Care Amidst Flat US Growth and Downward Financial Adjustments
- Fresenius Medical Care Reports Modest Growth in 2025 Earnings
- Fresenius Medical Care’s Earnings Call Highlights Growth Amid Challenges
- Fresenius Medical Care Restructures with New Value-Based Care Segment
- Fresenius Medical reports Q2 adjusted EPS EUR0.91 vs. EUR0.72 last year